CION Ameerpet
When a scan or test raises the possibility of cancer, a biopsy for cancer diagnosis is the gold standard for finding out for certain. It is the only test that can confirm whether a lump or abnormality is cancer, identify exactly what type it is, and reveal the features that guide treatment — in other words, almost everything in a cancer treatment plan flows from the biopsy. At CION Cancer Clinics, biopsies are performed by specialists, read by pathologists, and discussed by a tumour board, so you get a clear answer and a plan.
Scans such as ultrasound, CT, MRI and PET-CT can find a mass and measure it, and blood tests can raise suspicion — but none of them can tell for certain whether something is cancer, or what type it is. That needs a sample of the actual tissue or cells, examined under a microscope by a pathologist. This is why a biopsy is described as the gold standard for a cancer diagnosis.
A scan answers where and how big; the biopsy answers what it actually is. For more on how the two fit together, see MRI for cancer diagnosis & staging and the PET-CT scan.
Imaging can find and measure a mass, but only a biopsy can confirm whether it is cancer and what type. As the U.S. National Cancer Institute explains, a tissue diagnosis is the basis of cancer care.
The sample is examined as either histopathology (a piece of tissue, showing how the cells are arranged) or cytopathology (individual cells, as in FNAC). The pathologist confirms whether cancer is present, identifies the type, and looks at features such as how abnormal the cells are — information that a scan simply cannot provide.
The kind of biopsy taken affects what the pathologist can do with it. For a simple guide to each method, see the types of biopsy.
Your pathology report is the document that brings it all together. In general terms, it states whether the sample is benign or malignant, the type of cancer if present, the grade (how aggressive the cells look), the margins (whether a removed lesion has a clear rim of normal tissue), and the results of any special tests. Your oncologist explains what your specific report means for you.
Wondering how soon the report comes back? See how long biopsy results take and how to read your report.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bring your prescription, scan or report. Our oncologists help you understand whether a biopsy is needed — and you're welcome to a free written second opinion before you commit to anything.
Modern cancer care often depends on special tests run on the biopsy sample. Immunohistochemistry (IHC) detects specific proteins — for example ER, PR and HER2 in breast cancer — and molecular or genomic tests look for changes that can be matched to targeted therapy or immunotherapy. These tests need enough good-quality tissue, which is one reason a core biopsy is often preferred over an FNAC for a solid tumour.
To understand the trade-off between cell and tissue sampling, see the types of biopsy.
These two terms are often confused. The grade — how abnormal and fast-growing the cells look — comes from the biopsy. The stage — how far the cancer has spread — is worked out by combining the biopsy with imaging such as CT, MRI or PET-CT. Both matter: grade describes the cancer's nature, while stage describes its extent, and together they shape treatment.
For how imaging contributes to staging, see MRI for cancer diagnosis & staging and the PET-CT scan.
Imaging and biopsy are not alternatives — they answer different questions. Imaging finds a suspicious area, measures it, and helps assess spread; the biopsy then tells you exactly what it is. Together they give the complete picture needed to plan treatment.
At CION, biopsy and pathology results are discussed by a multidisciplinary tumour board — medical, surgical and radiation oncologists together — so the plan reflects more than one specialist's view. You are also welcome to a free written second opinion on an outside biopsy or pathology report.
This is a common worry, but it is not supported by medical evidence — a biopsy does not cause cancer to spread through the body. The needle-track seeding that people fear is extremely rare, and precautions are taken against it. The real risk lies in delaying or avoiding a recommended biopsy, because that delays diagnosis and treatment. We answer this fully on our dedicated page: does a biopsy spread cancer?
Once the biopsy confirms the type, grade and molecular features of a cancer, your oncology team can build a plan — which may involve surgery, chemotherapy, radiotherapy, targeted therapy or immunotherapy, alone or in combination. The clearer and more complete the biopsy information, the more precisely treatment can be tailored to you.
This is a cornerstone page on how a biopsy diagnoses cancer. To go deeper on a method, comparison or concern, these guides help:
This page is for general information only and is not a substitute for professional medical advice, diagnosis or treatment. Always follow the advice of a qualified doctor regarding which test or biopsy is appropriate for you and how to interpret the results.
Hear from the patients and families who came to CION for diagnosis, biopsy and cancer care — in their own words.
Because it is the only test that can confirm for certain whether something is cancer and identify its type. Scans and blood tests can raise suspicion, but only examining the actual tissue gives a definite diagnosis.
No. Scans such as CT, MRI and PET-CT can find and measure a mass and assess spread, but they cannot confirm whether it is cancer or what type. A biopsy is needed for that.
In general, it states whether the sample is benign or malignant, the type of cancer if present, the grade, the margins (for a removed lesion), and the results of special tests such as IHC or molecular testing. Your oncologist explains your specific report.
Grade – how abnormal and fast-growing the cells look – comes from the biopsy. Stage – how far the cancer has spread – is determined by combining the biopsy with imaging. Both guide treatment.
They are special tests run on the biopsy sample. IHC detects specific proteins (such as ER, PR and HER2), and molecular tests look for changes that can be matched to targeted therapy or immunotherapy. They need enough good-quality tissue.
No – this is not supported by medical evidence. Needle-track seeding is extremely rare and precautions are taken. Delaying a recommended biopsy is the real risk, as it delays diagnosis and treatment.
A histopathology report usually takes about 3–7 working days; special tests such as IHC or molecular testing take longer. At CION, results are reviewed by a tumour board and explained with a clear next step.